celecoxib has been researched along with hydroxyl radical in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Banerjee, R; Mohanakumar, KP; Sairam, K; Saravanan, KS | 1 |
| Chen, KH; Chiang, LL; Lee, HL; Su, CL; Wang, D; Yuan, DW | 1 |
2 other study(ies) available for celecoxib and hydroxyl radical
| Article | Year |
|---|---|
Non-steroidal anti-inflammatory drug sodium salicylate, but not diclofenac or celecoxib, protects against 1-methyl-4-phenyl pyridinium-induced dopaminergic neurotoxicity in rats.
Topics: 1-Methyl-4-phenylpyridinium; Animals; Anti-Inflammatory Agents, Non-Steroidal; Celecoxib; Corpus Striatum; Diclofenac; Dopamine; Dose-Response Relationship, Drug; Drug Interactions; Gentisates; Hydroxybenzoates; Hydroxyl Radical; In Vitro Techniques; Male; Mortality; Neurodegenerative Diseases; Neuroprotective Agents; Pyrazoles; Rats; Rats, Inbred Strains; Rats, Sprague-Dawley; Sodium Salicylate; Sulfonamides | 2003 |
Inducible cyclooxygenase expression mediating hypoxia/reoxygenation-induced pulmonary vasoconstriction is attenuated by a cyclooxygenase inhibitor in rats.
Topics: Animals; Biomarkers; Blood Pressure; Celecoxib; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Disease Models, Animal; Hydroxyl Radical; Hypoxia; Inflammation Mediators; Nitric Oxide; Oxidative Stress; Perfusion; Pulmonary Artery; Pyrazoles; Rats; Rats, Sprague-Dawley; RNA, Messenger; Sulfonamides; Thromboxane B2; Time Factors; Vasoconstriction | 2012 |